Screener
Apogee Therapeutics, Inc. APGE Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | MARCH 31,2026 | DECEMBER 31,2025 |
|---|---|---|
| Total liabilities | 37,861 | 33,251 |
| Commitments and contingencies (Note 9) | ||
| Stockholders' equity: | ||
| Common Stock; $0.00001 par value, 400,000,000 authorized, 75,323,726 issued and 74,882,396 outstanding as of March 31, 2026; 400,000,000 authorized, 69,038,943 issued and 68,401,349 outstanding as of December 31, 2025 | 1 | 1 |
| Additional paid-in capital | 1,892,411 | 1,464,561 |
| Accumulated other comprehensive income (loss) | (749) | 1,080 |
| Accumulated deficit | (635,870) | (561,759) |
| Total stockholders’ equity | 1,255,793 | 903,883 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s common stock?
- Apogee Therapeutics, Inc. (APGE) reported common stock of $1K in Q1 2026.
- How has Apogee Therapeutics, Inc.'s common stock changed year-over-year?
- Apogee Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from $1K to $1K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Apogee Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude